首页> 外国专利> Preparation of salt 5 - (R) - 2 - (5,6-diethyl-ndan-2-ethyl) - 1-hydroxy-ethyl - 8-hydroxy - (1H) - quinoline-2-ona

Preparation of salt 5 - (R) - 2 - (5,6-diethyl-ndan-2-ethyl) - 1-hydroxy-ethyl - 8-hydroxy - (1H) - quinoline-2-ona

机译:制备盐5-[(R)-2-(5,6-二乙基-ndan-2-乙基)-1-羟基-乙基]-8-羟基-(1H)-喹啉-2-ona

摘要

It refers to the preparation procedure of salt 5 [(R) - 2 - (5). 6-dietil-indan-2-ilamino-1-hydroxi-ethi] - 8-hydroxi - (1H) - quinolin-2-ona, including: (a) oxi-5 - (R) - oxinal - (1H) - quinolin-2-ona 8 is replaced by 2-amine - (5-6-dietil) to form a reaction mixture, which contains a protective group of compounds; (b) When the solvent forms the corresponding salt, the mixed reaction is treated in the acid; (c) the salt is separated and crystallized;(d) In the presence of solvent, the salt protection group is removed to obtain a compound, and finally in the presence of solvent, when 5 - [(R) - 2 - (5,6-dietil-indan-2-ilamin o) - 1-hydroxi-ethi] - 8-hydroxi - (1H) - quinolin-2-one de formula VII, X is anion, it is treated in acid solution. These compounds are adrenaline selective agonists and can be used in the treatment of asthma and EPOC.
机译:它是指盐5 [(R)-2-(5)的制备过程。 [6-ditil-indan-2-ilamino-1-hydroxi-ethi]-8-hydroxi-(1H)-quinolin-2-ona,包括:(a)oxi-5-(R)-oxinal-(1H)-喹啉-2-ona 8被2-胺-(5-6-dietil)取代,形成反应混合物,其中含有化合物的保护基; (b)当溶剂形成相应的盐时,在酸中处理混合反应; (c)将盐分离并结晶;(d)在溶剂存在下,当5-[[R] -2-(5)时,除去盐保护基以获得化合物,最后在溶剂存在下。 ,6-二对-茚满-2-ilamin o)-1-hydroxi-ethi]-8-hydroxi-(1H)-quinolin-2-one de式VII,X为阴离子,在酸性溶液中处理。这些化合物是肾上腺素选择性激动剂,可用于治疗哮喘和EPOC。

著录项

  • 公开/公告号PE20040956A1

    专利类型

  • 公开/公告日2005-01-20

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号PE19980200400

  • 发明设计人 LOHSE OLIVIER;VOGEL CASPAR;

    申请日2004-02-26

  • 分类号C07D215/26;

  • 国家 PE

  • 入库时间 2022-08-21 22:16:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号